GENEREX BIOTECHNOLOGY CORP | Business Finance | Business Contracts

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on September 3, 2020)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on September 3, 2020)

Form of Series D Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

STOCK PURCHASE AGREEMENT CONFIDENTIAL DRAFT: for discussion Purposes ONLY (Filed With SEC on November 27, 2019)

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 11, 2019)

PLEDGE AND SECURITY AGREEMENT CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)

AMENDED AND RESTATED SHAREHOLDERS AGREEMENT (Filed With SEC on January 11, 2019)

Form of Series C Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series B Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

Form of Series A Common Stock Purchase Warrant (Filed With SEC on August 7, 2020)

THEISSUE PRICE OF THIS NOTE IS $100,000.00 (Filed With SEC on June 22, 2020)

THEISSUE PRICE OF THIS NOTE IS $50,000.00 (Filed With SEC on June 22, 2020)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 18, 2020)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 18, 2020)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 22, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 22, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 22, 2019)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 15, 2019)

COMMON STOCK PURCHASE WARRANT GENEREX BIOTECHNOLOGY CORPORATION (Filed With SEC on February 15, 2019)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 15, 2019)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2019)

PROMISSORY NOTE CONFIDENTIAL DRAFT: FOR DISCUSSION PURPOSES ONLY (Filed With SEC on January 11, 2019)

PROMISSORY NOTE (Filed With SEC on January 11, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)

PLEDGE AND SECURITY AGREEMENT (Filed With SEC on January 11, 2019)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 11, 2019)

GENEREX BIOTECHNOLOGY CORP (44) | Business Finance (28)